Future Treatment Options for Hepatitis C
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The future of hepatitis C treatment looks bright -- most likely with the new oral, protease and polymerase inhibitors currently in development. Although these agents represent an exciting phase in the development of effective hepatitis C therapy, they are still a few years away from being recommended for routine clinical use. What can we look forward to? Expert hepatologist Dr. Jorge Herrera joins host Dr. Leslie Lundt to discuss the latest research in Hepatitis C treatments.
Overview
The future of hepatitis C treatment looks bright -- most likely with the new oral, protease and polymerase inhibitors currently in development. Although these agents represent an exciting phase in the development of effective hepatitis C therapy, they are still a few years away from being recommended for routine clinical use. What can we look forward to? Expert hepatologist Dr. Jorge Herrera joins host Dr. Leslie Lundt to discuss the latest research in Hepatitis C treatments.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Diagnosis and Management of Metastatic PDAC
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Partnering with Patients: Building Effective Communication and Support in HF Care
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?